JG
OMED

Jefferies Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Jefferies Group’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-26,480
Closed -$405K – 2517
2013
Q3 		$405K Buy
+26,480
New +$491K ﹤0.01% 1290

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group's OMED Position: Q4 2013 in Review

Jefferies Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2013, closing a stake of 26,480 shares — an estimated $405K sold.

Jefferies Group first reported a position in OMED in Q3 2013 and held it in 1 quarter. The position peaked at $405K in Q3 2013. 55 funds tracked by Wall St. Rank hold OMED as of Q4 2013.

  • Jefferies Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Jefferies Group sold 26,480 OncoMed Pharmaceuticals, Inc. shares in Q4 2013, an estimated $405K.
  • Jefferies Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 1 quarter.
  • Jefferies Group's OncoMed Pharmaceuticals, Inc. position peaked at $405K in Q3 2013.
  • 55 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2013.

Based on Jefferies Group's 13F filing for Q4 2013, filed 18 Feb 2014.